John L Gore, MD - Medicare Urology in Seattle, WA

John L Gore, MD is a medicare enrolled "Urology" physician in Seattle, Washington. He went to Baylor College Of Medicine and graduated in 2001 and has 23 years of diverse experience with area of expertise as Urology. He is a member of the group practice The Association Of University Physicians and his current practice location is 1959 Ne Pacific St, Seattle, Washington. You can reach out to his office (for appointments etc.) via phone at (206) 598-4294.

John L Gore is licensed to practice in Washington (license number MD60091579) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1265553374.

Contact Information

John L Gore, MD
1959 Ne Pacific St,
Seattle, WA 98195-0001
(206) 598-4294
Not Available



Physician's Profile

Full NameJohn L Gore
GenderMale
SpecialityUrology
Experience23 Years
Location1959 Ne Pacific St, Seattle, Washington
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • John L Gore attended and graduated from Baylor College Of Medicine in 2001
  NPI Data:
  • NPI Number: 1265553374
  • Provider Enumeration Date: 04/03/2007
  • Last Update Date: 08/12/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 4789776733
  • Enrollment ID: I20090909000330

Medical Identifiers

Medical identifiers for John L Gore such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1265553374NPI-NPPES
00A836520MedicaidCA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology A83652 (California)Secondary
208800000XUrology MD60091579 (Washington)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Washington Medical CtrSeattle, WAHospital
Olympic Medical CenterPort angeles, WAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Association Of University Physicians04461626973009

News Archive

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

Positive top-line results from Idera's IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

Knowing when and how to taper off opioid dosage crucial to safe pain management

Many healthcare providers today try to avoid administering or prescribing opioid pain medications when possible because of the narcotics' addictive properties. But for some patients, opioid medications remain the most effective, most appropriate treatment for their subjective pain complaints.

Drinking or smoking while breastfeeding and affects later cognition in children

According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.

Study offers new insight into the role of tau proteins in ALS pathogenesis

A team led by investigators at Massachusetts General Hospital has shown that people living with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, who carry a mutation in the C9orf72 gene exhibit elevated levels of tau and phosphorylated tau protein in the motor cortex region of the brain.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. John L Gore allows following entities to bill medicare on his behalf.
Entity NameThe Association Of University Physicians
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023041159
PECOS PAC ID: 0446162697
Enrollment ID: O20031105000244

News Archive

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

Positive top-line results from Idera's IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

Knowing when and how to taper off opioid dosage crucial to safe pain management

Many healthcare providers today try to avoid administering or prescribing opioid pain medications when possible because of the narcotics' addictive properties. But for some patients, opioid medications remain the most effective, most appropriate treatment for their subjective pain complaints.

Drinking or smoking while breastfeeding and affects later cognition in children

According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.

Study offers new insight into the role of tau proteins in ALS pathogenesis

A team led by investigators at Massachusetts General Hospital has shown that people living with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, who carry a mutation in the C9orf72 gene exhibit elevated levels of tau and phosphorylated tau protein in the motor cortex region of the brain.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John L Gore is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
John L Gore, MD
Po Box 50095,
Seattle, WA 98145-5095

Ph: () -
John L Gore, MD
1959 Ne Pacific St,
Seattle, WA 98195-0001

Ph: (206) 598-4294

News Archive

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

Positive top-line results from Idera's IMO-3100 Phase 2a trial on plaque psoriasis

Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.

Knowing when and how to taper off opioid dosage crucial to safe pain management

Many healthcare providers today try to avoid administering or prescribing opioid pain medications when possible because of the narcotics' addictive properties. But for some patients, opioid medications remain the most effective, most appropriate treatment for their subjective pain complaints.

Drinking or smoking while breastfeeding and affects later cognition in children

According to a new study published this week in the journal Pediatrics, quite a few breast feeding women are not abstaining from alcohol and are thus causing exposure of their babies to alcohol. They write in their study that children who are exposed to alcohol in the breast milk that they take are likely to have lower cognitive abilities.

Study offers new insight into the role of tau proteins in ALS pathogenesis

A team led by investigators at Massachusetts General Hospital has shown that people living with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, who carry a mutation in the C9orf72 gene exhibit elevated levels of tau and phosphorylated tau protein in the motor cortex region of the brain.

Read more News

› Verified 5 days ago


Urology Doctors in Seattle, WA

Dr. Sandra Jane Hadjinian, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1959 Ne Pacific St., Seattle, WA 98195
Phone: 206-520-5000    
Dr. Steven Han, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 515 Minor Ave, Suite 200, Seattle, WA 98104
Phone: 206-215-2580    Fax: 206-215-2581
John Steele Mullen, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 515 Minor Ave, Suite 200, Seattle, WA 98104
Phone: 206-215-2580    Fax: 206-215-2581
Jeffrey M Mccracken, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 747 Broadway, Seattle, WA 98122
Phone: 206-386-2043    Fax: 206-386-2508
Dr. Carol Collins, MD
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 272 Health Sciences, 1959 Ne Pacific St, Seattle, WA 98195
Phone: 206-616-3294    
Dr. Daniel Warren Smith, MD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 9709 3rd Ave Ne, Seattle, WA 98115
Phone: 206-860-4944    
Tristan Marriner Nicholson, MD, PHD
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1959 Ne Pacific St, Seattle, WA 98195
Phone: 206-520-5000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.